Marco Rüedi
Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management. He is also currently a mentor for the Tech4Eva program at EPFL Innovation Park.
He is a strong believer in well-balanced teams: motivated to challenge the status quo!
Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.
He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Berne, and an Executive Masters in Business Administration from eMBA PHW Berne.
Kerry Briggs
Matthieu Vallin
Matthieu Vallin joined Octopus Ventures in 2020 and focuses on sourcing and qualifying early-stage investments that will transform healthcare and life sciences. From consumer health through to advances in drug discovery, he liaises with entrepreneurs who have a drive to bring the most benefits to the delivery of care and patient outcomes.
Eileen Buttimer
Eileen Buttimer is Senior Vice President of New Business Development at Sagentia Innovation and has over 20 years’ experience exploring innovation opportunities with clients across multiple sectors including consumer health, pharma and med tech. She is particularly passionate about driving innovation in the Women’s Health space. Eileen is a strong professional skilled in International Business, Innovation Management, Entrepreneurship and Market Analysis. She holds a PhD in Biochemistry and an MBA and prior to Sagentia Innovation, she has held R&D management positions in DuPont and Pfizer.
Avi Gesser
Shannon Altimari
Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.
Shannon Altimari
Shannon joined GSK in 2020 as the company’s Global Head of Oncology Advocacy to Outcomes. In this role, she leads GSK’s oncology patient advocacy strategies, with a focus on improving outcomes and supporting equitable access for patients. Prior to GSK, she was with TESARO Bio GmbH as Head of International Corporate Affairs. Before TESARO, she spent 10 years with Biogen. She is an American citizen currently living in Switzerland.
